Every baby in England to get life-saving genetic test from birth

• England's newborn screening programme will expand to include spinal muscular atrophy (SMA), offering universal genetic testing for all infants at birth
• Early detection through newborn screening enables prompt treatment initiation, improving outcomes for this severe neuromuscular condition
• GPs and paediatricians should anticipate increased referrals for SMA diagnosis and familiarise themselves with available disease-modifying therapies for affected infants

All babies in England will be screened for spinal muscular atrophy (SMA).

ClinicaliQ summarises and contextualises external updates for clinical awareness, then links to the original publisher for the full article and most current context.